Literature DB >> 21199360

Response to questions regarding the design and results of the IMPACT trial.

Atul Humar, P Peeters, D Abramowicz, A Humar, Y Lebranchu, I Hauser, A Jardine, A P Limaye, F Vincenti, J D Punch, E Blumberg.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21199360     DOI： 10.1111/j.1600-6143.2010.03370.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  2 in total

Review 1.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

2.  Cytomegalovirus disease in African-American kidney transplant patients.

Authors:  J McGee; V Mave; C L Yau; M Killackey; A Paramesh; J Buell; D P Slakey; L L Hamm; R Zhang
Journal:  Transpl Infect Dis       Date:  2012-12       Impact factor: 2.228
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.